India : Life sciences AI company recognised at the 2026 Minsky Awards for Excellence in AI
Improzo, a US-Headquartered AI and data solutions company focused on life sciences, has been named “Best Growth Stage AI Startup” at the 2026 Minsky Awards for Excellence in AI, presented by AIM at Cypher 2026. Cypher, India’s flagship AI summit, that marked its 10th edition this year with more than 7,000 attendees and over 150 speakers. The award was presented by badminton icon and Padma Bhushan recipient Pullela Gopichand.
The recognition follows another milestone from earlier this year. On August 22, Improzo placed second in the Startup Showcase at the IIM Ahmedabad Healthcare AI Summit 2026. Organised by the Indian Institute of Management Ahmedabad, the summit brought together leaders from government, industry and academia around the theme “Advancing AI in Healthcare.”
“Being named Best Growth Stage AI Startup at Cypher and receiving the award from Pullela Gopichand is a moment our whole team will remember,” said Abhishek Trigunait, CoFounder and CPTO, Improzo.
“It recognises the pace at which we have grown and the impact we are creating in life sciences. Coming after our second-place finish at IIM Ahmedabad, it tells us we are solving a real problem. These honours belong to our customers, our partners, and a team that shows up every day wanting this work to matter.”
At the heart of Improzo’s journey is iZO®, its AI-powered Application Execution Layer for Life Sciences. It helps pharmaceutical companies run complex commercial, medical, and enterprise workflows with far less friction, moving beyond AI experimentation to execution at enterprise scale.
Speaking about the company’s focus, Abhishek Trigunait said: “We work only in life sciences, and that focus is our strength. Pharma, med-device and animal health companies don’t need more AI pilots. They need AI that fits into how they actually work, across commercial, medical and enterprise functions. That’s what we are building, and we are only getting started.”
Improzo builds its suite of AI applications on swappable infrastructure layers. It combines data, AI, and technology with deep domain expertise to support personalised customer engagement, operational efficiency, and sharper therapeutic insights.
****